← Back to contracts

Novel Gene Therapy, Techniques, and Devices to Prevent Ventricular Tachycardia

US National Heart Lung and Blood Institute grant open #nih-4R44HL172541-02

Summary

ABSTRACT In the United States, several hundred thousand people experience cardiac arrest each year, with the vast majority dying from this condition. Approximately two-thirds of cardiac arrest victims have previously suffered a myocardial infarction (MI), and death results from maladaptive responses to infarct healing. The healed infarct scar creates a substrate that supports malignant ventricular arrhythmias, and death results from ventricular tachycardia (VT) originating in the border zone around the infarct scar. We recently reported that the potassium channel beta subunits KCNE3 and KCNE4

Novel Gene Therapy, Techniques, and Device…
Onboard